Mark Jones
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Organic Chemistry top 5%
- Ferrocene Chemistry and Applications
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- Viral gastroenteritis research and epidemiology 6
- COVID-19 Clinical Research Studies 5
- Co-authors
- T.A. ConnorsAbdul R. KhokharP.D. BraddockM. L. TOBEKenneth R. HarrapA H CalvertAnn L. JackmanTerence R. Jones
- Journals
- Trials (6 papers)British Journal of Cancer (4 papers)Biochemical Pharmacology (3 papers)Chemico-Biological Interactions (2 papers)Vaccine (2 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Mark Jones
90 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 140
- Oncology 728
- Organic Chemistry 429
- Hepatology 77
- Ophthalmology 78
- Endocrine and Autonomic Systems 48
Countries citing papers authored by Mark Jones
This map shows the geographic impact of Mark Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jones more than expected).
Fields of papers citing papers by Mark Jones
This network shows the impact of papers produced by Mark Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jones. The network helps show where Mark Jones may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 0 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 11 | |
| 12 | 2019 | 17 | |
| 13 | 2018 | 37 | |
| 14 | European registry for quality improvement in corneal transplantation surgery | 2018 | 1 |
| 15 | 2017 | 8 | |
| 16 | 2009 | 1 | |
| 17 | Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients | 2007 | 1 |
| 18 | A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity. | 1994 | 116 |
| 19 | 1990 | 33 | |
| 20 | Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA, JM8) in mice and rats | 1982 | 4 |
About Mark Jones
Mark Jones is a scholar working on Ophthalmology, Infectious Diseases, Hepatology, Public Health, Environmental and Occupational Health and Oncology, having authored 97 papers that have together received 1.8k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (10 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Viral gastroenteritis research and epidemiology (6 papers), Organ Donation and Transplantation (5 papers), Ferrocene Chemistry and Applications (5 papers), COVID-19 Clinical Research Studies (5 papers), Corneal surgery and disorders (5 papers) and Hepatitis Viruses Studies and Epidemiology (3 papers). The work is most often cited by research in Oncology (728 citations), Organic Chemistry (429 citations), Hepatology (77 citations), Ophthalmology (78 citations) and Endocrine and Autonomic Systems (48 citations). Mark Jones has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include T.A. Connors, Abdul R. Khokhar, P.D. Braddock, M. L. TOBE, Kenneth R. Harrap, A H Calvert, Ann L. Jackman, Terence R. Jones, K.R. Harrap and Lloyd R. Kèlland. Their work appears in journals such as Trials, British Journal of Cancer, Biochemical Pharmacology, Chemico-Biological Interactions and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.